Epygenix Therapeutics Announces Appointment of G. Michael Landis as Chief Financial Officer
23 mars 2022 07h00 HE
|
Epygenix Therapeutics, Inc.
PARAMUS, N.J., March 23, 2022 (GLOBE NEWSWIRE) -- Epygenix Therapeutics, a clinical-stage biopharmaceutical company developing drugs for rare and intractable forms of genetic epilepsy, announces the...